{"transactions":[{"id":778890,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-14T21:47:02.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."}],"balance_after":22700,"derivative":{"exercise_price":13.28,"exercise_date":"2027-05-12","expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001999371-26-010752","document":"bell-form4_051426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126010752/bell-form4_051426.xml","form_type":"4"}},{"id":1147250,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-15T21:00:55.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."}],"balance_after":10000,"derivative":{"exercise_price":20.18,"exercise_date":"2026-05-13","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001999371-25-006253","document":"bell-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125006253/bell-form4.xml","form_type":"4"}},{"id":1238302,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2025-02-28T22:32:22.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":1,"price":0.15,"value":0.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Involuntary sale of fractional shares following a reverse stock split of the Issuer's common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001839882-25-012474","document":"bell-form4_022825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225012474/bell-form4_022825.xml","form_type":"4"}},{"id":1501830,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-05-24T21:05:04.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":104621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":104621,"derivative":{"exercise_price":0.1745,"exercise_date":"2025-05-23","expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":104621},"source":{"system":"sec-edgar","filing":"0001999371-24-006618","document":"bell-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124006618/bell-form4.xml","form_type":"4"}},{"id":1898035,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-05-10T21:14:39.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."}],"balance_after":60000,"derivative":{"exercise_price":0.509,"exercise_date":"2024-05-08","expiration_date":"2033-05-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001839882-23-012504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223012504/ownership.xml","form_type":"4"}},{"id":2274669,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-11T21:44:06.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":2131500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":2131500,"derivative":{"exercise_price":0.132,"exercise_date":"2023-05-09","expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":2131500},"source":{"system":"sec-edgar","filing":"0001387131-22-006017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122006017/ownership.xml","form_type":"4"}},{"id":2716244,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-05-12T20:42:49.000Z","date":"2021-05-10","kind":"grant","acquired":true,"shares":270882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":270882,"derivative":{"exercise_price":1.03,"exercise_date":"2022-05-10","expiration_date":"2031-05-10","underlying":"Common Stock","underlying_shares":270882},"source":{"system":"sec-edgar","filing":"0001387131-21-005543","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713121005543/ownership.xml","form_type":"4"}},{"id":3048605,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2020-08-24T13:00:11.000Z","date":"2020-08-20","kind":"purchase","acquired":true,"shares":5391,"price":0.927,"value":4997.457,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.9262 to $0.9273, inclusive. The reporting person undertakes to provide to Tonix Pharmaceuticals Holding Corp., any security holder of Tonix Pharmaceuticals Holding Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth herein."}],"balance_after":5391,"source":{"system":"sec-edgar","filing":"0001387131-20-007758","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120007758/ownership.xml","form_type":"4"}},{"id":3159355,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-05-06T22:39:42.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":75000,"derivative":{"exercise_price":0.77,"exercise_date":"2021-05-04","expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001387131-20-004499","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120004499/ownership.xml","form_type":"4"}},{"id":3535053,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-05-08T11:17:18.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan."}],"balance_after":30000,"derivative":{"exercise_price":2.05,"exercise_date":"2020-05-06","expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001387131-19-003410","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119003410/ownership.xml","form_type":"4"}},{"id":3895371,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-06-13T21:14:54.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan."}],"balance_after":20000,"derivative":{"exercise_price":4.25,"exercise_date":"2019-06-12","expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001615774-18-005231","document":"s110811_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418005231/s110811_form4.xml","form_type":"4"}}]}